Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HIV prevention on wheels: PrEP pills offered on mobile van for drug users

NCT ID NCT06908252

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 28 times

Summary

This study tests whether giving HIV prevention pills (PrEP) on a medical van is a good way to reach people who inject drugs and are at high risk for HIV. The researchers will enroll 20 adults who use drugs or are sexually active and see how many start and stay on PrEP. The goal is to see if this mobile approach helps prevent HIV in a hard-to-reach group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Duke Department of Population Health Sciences

    RECRUITING

    Durham, North Carolina, 27701, United States

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pre-Exposure Prophylaxis (PrEP) pills

What this could lead to

If this works, it could show that offering HIV prevention pills on a mobile medical van is an effective way to reach people who inject drugs and help prevent HIV.

What could go wrong

This is a very small early-stage study with only 20 participants, so results may not apply to larger groups. It focuses on feasibility, not on proving the pills prevent HIV.

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.